Glycogenin 1 抗体 (AA 314-347)
Quick Overview for Glycogenin 1 抗体 (AA 314-347) (ABIN6242722)
抗原
See all Glycogenin 1 (GYG1) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            抗原表位
- AA 314-347
- 
                                            预测反应
- M, Rat
- 
                                            纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- 
                                            免疫原
- This GYG1 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 314-347 amino acids from human GYG1.
- 
                                            亚型
- Ig Fraction
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- WB: 1:2000. FC: 1:25
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            有效期
- 6 months
 
- 
                                            
- 
    - Glycogenin 1 (GYG1)
- 
                                            别名
- GYG1
- 
                                            背景
- Self-glucosylates, via an inter-subunit mechanism, to form an oligosaccharide primer that serves as substrate for glycogen synthase.
- 
                                            分子量
- 39384
- 
                                            UniProt
- P46976
- 
                                            途径
- Cellular Glucan Metabolic Process
 抗原
- 
                    
 
                                     
                                     
                                    